Metraipolis › archive › dc_0d466e7ee515
Trastuzumab and Pertuzumab Suspected Therapy-Induced Ocular Toxicity in Patient Living with HER2-Positive Advanced Breast Cancer — Europe PMC PMID:42923999
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42923999
- DOI
- 10.1159/cro/abzag014
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T05:53:01.199Z
- SHA-256 of the archived text
f44117190554b857bda5cf1a31080f5438575abc94f06c05a051f29aedac154f- Stable URL of this page
https://metraipolis.com/documento/dc_0d466e7ee515
How to cite
Trastuzumab and Pertuzumab Suspected Therapy-Induced Ocular Toxicity in Patient Living with HER2-Positive Advanced Breast Cancer — Europe PMC PMID:42923999 — Europe PMC (en), https://europepmc.org/article/MED/42923999 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0d466e7ee515 (Metraipolis archive dc_0d466e7ee515, sha256 f44117190554b857bda5cf1a31080f5438575abc94f06c05a051f29aedac154f)
BibTeX
@misc{dc0d466e7ee515,
title = {Trastuzumab and Pertuzumab Suspected Therapy-Induced Ocular Toxicity in Patient Living with HER2-Positive Advanced Breast Cancer — Europe PMC PMID:42923999},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42923999},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0d466e7ee515; sha256 f44117190554b857bda5cf1a31080f5438575abc94f06c05a051f29aedac154f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42923999. Agents can read the archived copy with the MCP tool read_document.